- Home
- VSTE vs NTRB Comparison
VSTE vs NTRB Comparison
Compare VSTE & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTE
- NTRB
- Stock Information
- Founded
- VSTE 2009
- NTRB 2016
- Country
- VSTE Australia
- NTRB United States
- Employees
- VSTE N/A
- NTRB N/A
- Industry
- VSTE
- NTRB Industrial Specialties
- Sector
- VSTE
- NTRB Health Care
- Exchange
- VSTE Nasdaq
- NTRB Nasdaq
- Market Cap
- VSTE 30.0M
- NTRB 77.9M
- IPO Year
- VSTE N/A
- NTRB N/A
- Fundamental
- Price
- VSTE $2.42
- NTRB $6.17
- Analyst Decision
- VSTE
- NTRB
- Analyst Count
- VSTE 0
- NTRB 0
- Target Price
- VSTE N/A
- NTRB N/A
- AVG Volume (30 Days)
- VSTE 14.1K
- NTRB 28.2K
- Earning Date
- VSTE 01-01-0001
- NTRB 12-11-2024
- Dividend Yield
- VSTE N/A
- NTRB N/A
- EPS Growth
- VSTE N/A
- NTRB N/A
- EPS
- VSTE N/A
- NTRB N/A
- Revenue
- VSTE $342,000.00
- NTRB $1,803,816.00
- Revenue This Year
- VSTE N/A
- NTRB N/A
- Revenue Next Year
- VSTE N/A
- NTRB N/A
- P/E Ratio
- VSTE N/A
- NTRB N/A
- Revenue Growth
- VSTE N/A
- NTRB N/A
- 52 Week Low
- VSTE $0.83
- NTRB $1.93
- 52 Week High
- VSTE $12.00
- NTRB $9.60
- Technical
- Relative Strength Index (RSI)
- VSTE 55.09
- NTRB 50.57
- Support Level
- VSTE $0.83
- NTRB $5.24
- Resistance Level
- VSTE $1.09
- NTRB $6.40
- Average True Range (ATR)
- VSTE 0.10
- NTRB 0.71
- MACD
- VSTE 0.03
- NTRB -0.12
- Stochastic Oscillator
- VSTE 92.08
- NTRB 33.23
About VSTE Vast Renewables Limited
Vast Renewables Ltd is a clean, renewable energy company specializing in the design and manufacturing of concentrated solar thermal power (CSP) systems to generate carbon-free, utility-scale electricity, industrial heat, and green fuels. The Company's differentiated modular CSP system, utilizing proprietary sodium loop heat transfer technology, provides customers with a solution to the enduring challenge of intermittent renewable energy through 24/7 dispatchable power and heat.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.